chr17-44372199-A-G
Variant summary
Our verdict is Uncertain significance. Variant got 6 ACMG points: 6P and 0B. PP4_StrongPM2_SupportingPM3_Supporting
This summary comes from the ClinGen Evidence Repository: The NM_000419.5(ITGA2B):c.*165T>C 3'UTR variant was identified homozygous (PM3_supporting) in at least one patient (GT75 in PMID:25728920) who displayed mucocutaneous bleeding and impaired aggregation with all agonists except ristocetin, which is highly specific for Glanzmann thrombasthenia. Additionally, αIIbβ3 surface expression was reduced to <5%, as measured by flow cytometry (PP4_strong). This variant is absent from gnomAD v3.1.2 (PM2_Supporting). ACMG/AMP criteria applied, as specified by the ClinGen PD VCEP: PP4_strong, PM2_supporting, PM3_supporting. (VCEP specifications version 2.1). These criteria reach Likely Pathogenic however, to our knowledge, there is no known disease mechanism for 3'UTR variants in Glanzmann thrombasthenia. In the absence of additional cases or functional data the ClinGen PD VCEP classifies this variant as uncertain significance for autosomal recessive Glanzmann Thrombasthenia. LINK:https://erepo.genome.network/evrepo/ui/classification/CA915940530/MONDO:0100326/011
Frequency
Consequence
NM_000419.5 3_prime_UTR
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ITGA2B | NM_000419.5 | c.*165T>C | 3_prime_UTR_variant | 30/30 | ENST00000262407.6 | ||
ITGA2B | XM_011524749.2 | c.*165T>C | 3_prime_UTR_variant | 29/29 | |||
ITGA2B | XM_011524750.2 | c.*165T>C | 3_prime_UTR_variant | 29/29 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ITGA2B | ENST00000262407.6 | c.*165T>C | 3_prime_UTR_variant | 30/30 | 1 | NM_000419.5 | P1 | ||
ITGA2B | ENST00000587295.5 | c.*165T>C | 3_prime_UTR_variant | 3/3 | 3 | ||||
ITGA2B | ENST00000648408.1 | c.*165T>C | 3_prime_UTR_variant | 25/25 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD4 exome Cov.: 6
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
Glanzmann thrombasthenia Uncertain:1
Uncertain significance, reviewed by expert panel | curation | ClinGen Platelet Disorders Variant Curation Expert Panel, ClinGen | Jun 02, 2022 | The NM_000419.5(ITGA2B):c.*165T>C 3'UTR variant was identified homozygous (PM3_supporting) in at least one patient (GT75 in PMID: 25728920) who displayed mucocutaneous bleeding and impaired aggregation with all agonists except ristocetin, which is highly specific for Glanzmann thrombasthenia. Additionally, alphaIIbbeta3 surface expression was reduced to <5%, as measured by flow cytometry (PP4_strong). This variant is absent from gnomAD v3.1.2 (PM2_Supporting). ACMG/AMP criteria applied, as specified by the ClinGen PD VCEP: PP4_strong, PM2_supporting, PM3_supporting. (VCEP specifications version 2.1). These criteria reach Likely Pathogenic however, to our knowledge, there is no known disease mechanism for 3'UTR variants in Glanzmann thrombasthenia. In the absence of additional cases or functional data the ClinGen PD VCEP classifies this variant as uncertain significance for autosomal recessive Glanzmann Thrombasthenia. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.